President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...

January, the Biden administration released its proposed Medicare Advantage rates in 2026. These are the rates that the ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, ...

The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department ...

Kennedy casts himself as “anti-establishment,” but he doesn’t object to the cruel profit-driven health care system that ...

The Chicago-based association will also "pick and choose" its advocacy fights regarding topics like vaccines, gender ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

During Bobby Kennedy Jr.’s contentious Senate confirmation hearing as HHS secretary nominee, he revealed that Medicaid costs ...